Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1527-7755

Journal

More filtering options
  1. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

    Joensuu, H., Mikael Eriksson, Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Nilsson, B., Sihto, H., Bono, P., Kallio, R., Junnila, J., Thor Alvegård & Reichardt, P., 2016, In : Journal of Clinical Oncology. 34, 3, p. 244-250

    Research output: Contribution to journalArticle

  2. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

    Jóhannsson, O. T., J Ranstam, Åke Borg & Håkan Olsson, 1998 Feb, In : Journal of Clinical Oncology. 16, 2, p. 397-404

    Research output: Contribution to journalArticle

  3. Quality of life in palliative cancer care: results from a cluster randomized trial

    Jordhoy, M. S., Fayers, P., Loge, J. H., Ahlner-Elmqvist, M. & Kaasa, S., 2001, In : Journal of Clinical Oncology. 19, 18, p. 3884-3894

    Research output: Contribution to journalArticle

  4. Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

    Kaiser, U., Uebelacker, L., Abel, U., Birkmann, J., Trumper, L., Schmalenberg, H., Karakas, T., Metzner, B., Hossfeld, DK., Bischoff, HG., Franke, A., Reiser, M., Muller, P., Mantovani, L., Grundeis, M., Rothmann, F., von Seydewitz, CU., Mesters, RM., Steinhauer, EU., Krahl, D. & 9 others, Schumacher, K., Kneba, M., Baudis, M., Schmitz, N., Pfab, R., Koppler, H., Parwaresch, R., Pfreundschuh, M. & Havemann, K., 2002, In : Journal of Clinical Oncology. 20, 22, p. 4413-4419

    Research output: Contribution to journalArticle

  5. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.

    Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M., Balmaña, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., Rosengarten, O., Steiner, M., Niklas Loman, Bowen, K., Fielding, A. & Domchek, S. M., 2015, In : Journal of Clinical Oncology. 33, 3, p. 244-U134

    Research output: Contribution to journalArticle

  6. Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.

    Knauf, W. U., Lissichkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Gunnar Juliusson, Postner, G., Gercheva, L., Goranov, S., Becker, M., Fricke, H-J., Huguet, F., Del Giudice, I., Klein, P., Tremmel, L., Merkle, K. & Montillo, M., 2009, In : Journal of Clinical Oncology. 27, p. 4378-4384

    Research output: Contribution to journalArticle

  7. Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5-Year Survivors of Childhood Cancer.

    Kovalchik, S. A., Ronckers, C. M., Veiga, L. H. S., Sigurdson, A. J., Inskip, P. D., de Vathaire, F., Sklar, C. A., Donaldson, S. S., Anderson, H., Bhatti, P., Hammond, S., Leisenring, W. M., Mertens, A. C., Smith, S. A., Stovall, M., Tucker, M. A., Weathers, R. E., Robison, L. L. & Pfeiffer, R. M., 2012, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  8. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer.

    Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., Sánchez, M. J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R. C., Khaw, K-T., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D. & 22 others, Peeters, P. H. M., Panico, S., Masala, G., Grioni, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Laurell, G., Hallmans, G., Jonas Manjer, Ekström, J., Skeie, G., Lund, E., Weiderpass Vainio, E., Ferrari, P., Byrnes, G., Romieu, I., Riboli, E., Hildesheim, A., Boeing, H., Pawlita, M. & Brennan, P., 2013, In : Journal of Clinical Oncology. 31, 21, p. 2708

    Research output: Contribution to journalArticle

  9. Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)

    Kurzeder, C., Bover, I., Marḿe, F., Rau, J., Pautier, P., Colombo, N., Lorusso, D., Ottevanger, P., Bjurberg, M., Marth, C., Barretina-Ginesta, P., Vergote, I., Floquet, A., Campo, J. M. D., Mahner, S., Bastíere-Truchot, L., Martin, N., Oestergaard, M. Z., Kiermaier, A., Schade-Brittinger, C. & 3 others, Polleis, S., Bois, A. D. & Gonzalez-Martin, A., 2016 Jul 20, In : Journal of Clinical Oncology. 34, 21, p. 2516-25 10 p.

    Research output: Contribution to journalArticle

Previous 12 3 4 5 6 7 8 9 ...12 Next